1-3 of 3
Peggy L Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Xavier Leleu, Thomas Delea, Patricia Guyot, Aaron Moynahan, Erin Singh, Christina Tekle, Peggy L Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6732.
https://doi.org/10.1182/blood-2023-188703
Published: 2023
Journal Articles

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Joshua Richter, Peggy L Lin, Viviana Garcia-Horton, Patricia Guyot, Zheng-Yi Zhou, Mark Sievert
Journal: Blood
Blood (2023) 142 (Supplement 1): 6734.
https://doi.org/10.1182/blood-2023-188582
Published: 2023
Journal Articles

Associations Between Joint Damage and Quality of Life Among Patients with Severe Hemophilia a in the 3-Year Spinart Trial

Jennifer Pocoski, PharmD, Peggy L Lin, PhD, Walter Hong, MD, Sneha S Kelkar, MS, MPH, Tianze Jiao, PhD, Ella X Du, MS, Thomas J. Humphries, MD, Jipan Xie, MD PhD
Journal: Blood
Blood (2014) 124 (21): 200.
https://doi.org/10.1182/blood.V124.21.200.200
Published: 2014